A solution to better align drug prices with clinical benefits

Drug access and transparency are prioritized while cost takes a back seat

There are many costs (and steps) to bring a drug to market

A spoonful of strategy helps the governance go down

Actuaries can play a key role in insurance product design and regulation

Pathways for insurance companies to realize innovation

New insurance regulations offer opportunities for improvement

LIBOR is going away—now what?

Perspectives from insurance regulators on the actuarial profession and the insurance industry

Insurers that rely on OTC derivatives may be affected by uncleared margin rules